Skip Ribbon Commands
Skip to main content
A- A A+

Find a Doctor

A/Prof Seet Chee Seong Raymond

Designations:
  • Senior Consultant, Division of Neurology, Department of Medicine, National University Hospital
  • Senior Consultant, Division of Neurology, Department of Medicine, Ng Teng Fong General Hospital
  • Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
  • Research Programme Director, Division of Neurology, National University Health System
Qualifications:
MBBS(S'pore), MRCP (UK), M Med (Int Med) (S'pore)
Specialties:
Medicine
Sub-Specialties:
Neurology

Biosketch

Dr Raymond Seet is a Senior Consultant at the Division of Neurology at the National University Hospital, and holds the academic rank of Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore. After completing his undergraduate and postgraduate training in Singapore, he completed his advanced fellowship in stroke and neurocritical care at the Mayo Clinic, Rochester. He is a Fellow of the Royal College of Physicians (FRCP, Edinburgh) and the Academy of Medicine of Singapore (FAMS).

Dr Seet’s clinical and research interests focus on:

  • Acute reperfusion treatment (intravenous thrombolysis and endovascular therapy) and the neurocritical care of stroke patients
  • Stroke prevention strategies focusing on atrial fibrillation and intracranial stenosis
  • Application of advances in stroke biology and technology to deliver personalised treatment to stroke patients
  • SARS-CoV-2 biology, diagnosis, thrombosis and interventions

Dr Seet has published over 170 international peer-reviewed articles. For his contributions in stroke, he was awarded the Inter-Academy Medical Panel Young Physician Leader Award during the World Health Summit in 2014. The following year, he received the Senior Clinician Scientist Award by the National Medical Research Council, Singapore. He is presently Editor-in-Chief of the Annals of the Academy of Medicine, Singapore, Assistant Editor of Stroke, Chairman of the Chapter of Neurologists, Academy of Medicine, Singapore, and President of the Clinical Neurosciences Society, Singapore. He is also Deputy Chairman of the Domain-Specific Review Board, National Healthcare Group, and Deputy Director of the Healthy Longevity Research Programme at the National University of Singapore.  

Dr Seet contributes actively to medical education and lectures undergraduates, post-graduates and specialists. He has special interest in bedside clinical teaching and clinical assessments. He attended the Harvard Medical International and the Royal College of Physician Programmes for Physician Educators. In 2008 and 2014, he was awarded both the faculty and university awards for teaching excellence (Faculty Teaching Excellence Award and Annual Teaching Excellence Award).

Journals & Publications

  1. Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 2011;124:477-86.
  2. Seet RC, Lee CY, Chan BP, Sharma VK, Teoh HL, Venketasubramanian N, Lim EC, Chong WL, Looi WF, Huang SH, Ong BK, Halliwell B. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 2011;42:2326-9.
  3. Seet RC, Wijdicks EF, Rabinstein A. Acute stroke from cervical internal carotid artery occlusion: treatment results and predictors of outcome. JAMA Neurology 2012; 24:1-6.
  4. Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, Chan YH, Halliwell B, Chen CP. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis 2010;209:215-9.
  5. Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovascular Diseases 2012;34:106-14.
  6. Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA. Stroke patients with chronic atrial fibrillation have worse outcomes after intravenous thrombolysis. JAMA Neurology 2011;68:1454-8. IF
  7. Seet RC, Zhang Y, Moore SA, Wijdicks EF, Rabinstein AA. Subtherapeutic INR in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage following intravenous thrombolysis. Stroke 2011;42:2333-5.
  8. Seet RC, Lee CY, Loke WM, Huang SH, Huang HW, Looi WF, Chew SE, Quek AM, Lim EC, Halliwell B. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radical Biology & Medicine 2011;50:1787-93. 
  9. Seet RC, Lee CY, Lim EC, Tan JH, Quek AM, Chong WL, Looi WF, Huang SH, Wang HS, Chan YH, Halliwell B. Oxidative damage in Parkinson disease. Measurement using accurate biomarkers. Free Radical Biology & Medicine 2010;48:560-6. 
  10. Seet RC, Rabinstein A, Christianson TJ, Petty GW, Brown RD.  Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. Journal of Stroke and Cerebrovascular Diseases 2013;22:561-9.


 

Back to Top